US EditionNew FDA-approved glasses can slow nearsightedness in kids
Essilor Stellest glasses, FDA-cleared in September, reduce myopia progression by 70% and eye lengthening by 50% in children aged 6–12, offering new treatment options.
- Now rolling out in the U.S., EssilorLuxottica won FDA clearance for Essilor Stellest spectacle lenses, citing company data showing a 70% reduction in myopia progression in children ages 6 to 12.
- Rising rates of childhood myopia show worldwide increases linked to indoor close work, with about 30% to 40% of U.S. children affected by high school and limited treatment options.
- Clinical trials reviewed by the FDA, done in Asia, showed children wearing the lens optical design had a 50% reduction in eye lengthening after two years.
- EssilorLuxottica set a $450 suggested retail price and major U.S. vision insurers are expected to cover children who meet prescribing criteria, while the FDA reported no serious side effects but noted some visual disturbances.
- U.S. researchers are now running independent trials to confirm company results, and Dr. Michael Repka leads a NIH-supported study while highlighting potential long-term risks like cataracts and glaucoma.
72 Articles
72 Articles
Why Is Myopia Increasing In Kids? New FDA-Approved Glasses Can Slow Near-sightedness In 6-12 Year Olds
Myopia, commonly called nearsightedness, is when people can clearly see objects at close range but struggle with distant objects, which often appear blurry or indistinct.
Associated Press News
New FDA-approved glasses can slow nearsightedness in kids
A new type of lens approved by the FDA promises to slow nearsightedness in children. These specialized glasses, available in the U.S. for the first time, aim to reduce the progression of myopia in kids aged 6 to 12.
FDA Approves New Glasses Designed to Slow Nearsightedness in Children
For many children, getting their first pair of glasses is a familiar childhood milestone. It marks the beginning of regular eye exams and a lifetime of vision care. But new technology now offers more than clearer sight. It may help protect long-term eye health and reduce the risk of serious vision problems later in life. A newly approved type of lens, cleared by the Food and Drug Administration in September, is being introduced across the United…
The administration of Food and Medicines in the United States (FDA) approved in September a new type of lens that promises to slow the development of myopia in children. Technology has existed for many years in Europe and Asia. It is now reaching the American market, and parents have completed an alternative to eye classes. What [...]
Coverage Details
Bias Distribution
- 71% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
